Literature DB >> 20574013

CFH and ARMS2 variations in age-related macular degeneration, polypoidal choroidal vasculopathy, and retinal angiomatous proliferation.

Hisako Hayashi1, Kenji Yamashiro, Norimoto Gotoh, Hideo Nakanishi, Isao Nakata, Akitaka Tsujikawa, Atsushi Otani, Masaaki Saito, Tomohiro Iida, Keitaro Matsuo, Kazuo Tajima, Ryo Yamada, Nagahisa Yoshimura.   

Abstract

PURPOSE: To seek an association in Japanese individuals between the CFH polymorphisms Y402H and I62V and the ARMS2 polymorphism A69S and age-related macular degeneration (AMD) or its three subtypes: typical (t)AMD, polypoidal choroidal vasculopathy (PCV), and retinal angiomatous proliferation (RAP).
METHODS: The three polymorphisms were genotyped in a case-control study of 1351 control subjects and 962 patients with AMD.
RESULTS: The three polymorphisms correlated with AMD (Y402H, P = 1.54 × 10(-6); I62V, P =1.94 × 10(-29); and A69S, P = 9.56 × 10(-43)). The I62V and A69S polymorphisms were associated with all three subtypes: tAMD (P = 3.74 × 10(-18) and 1.37 × 10(-35), respectively), PCV (P = 3.18 × 10(-19) and 3.96 × 10(-18), respectively), and RAP (P = 0.034 and 2.49 × 10(-18), respectively). Y402H was associated with tAMD (P = 3.00 × 10(-5)) and with PCV (P = 9.73 × 10(-5)), but no association was found with RAP, possibly because of the small sample size and the rare minor allele. The risk allele contribution of A69S was stronger for RAP than for tAMD or PCV and was stronger for tAMD than for PCV.
CONCLUSIONS: CFH Y402H is associated with AMD, tAMD, and PCV, whereas I62V is associated with all three subtypes. ARMS2 A69S has a strong association with all three subtypes, with the association being strongest for RAP and weakest for PCV. PCV and RAP may thus be subtypes of AMD that are genetically distinct from tAMD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20574013     DOI: 10.1167/iovs.10-5554

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  40 in total

1.  Association of ARMS2/HTRA1 variants with polypoidal choroidal vasculopathy phenotype in a Korean population.

Authors:  Dong Ho Park; In Taek Kim
Journal:  Jpn J Ophthalmol       Date:  2011-09-29       Impact factor: 2.447

2.  Two-year visual outcome of polypoidal choroidal vasculopathy treated with photodynamic therapy combined with intravitreal injections of ranibizumab.

Authors:  Masayuki Hata; Akitaka Tsujikawa; Masahiro Miyake; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Ayako Takahashi; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-30       Impact factor: 3.117

Review 3.  Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.

Authors:  Mohammad Hossein Jabbarpoor Bonyadi; Mehdi Yaseri; Mortaza Bonyadi; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2016-12-22       Impact factor: 2.031

4.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

5.  A clinical trial of somatic and germline analyses for healthy longevity in a postoperative cancer patient.

Authors:  Naoki Hayashi; Yosuke Kuroda; Tomoko Saito; Yusuke Tsuruda; Atsushi Niida; Hajime Otsu; Hidetoshi Eguchi; Takaaki Masuda; Yutaka Suzuki; Shoji Natsugoe; Koshi Mimori
Journal:  Surg Today       Date:  2019-03-06       Impact factor: 2.549

6.  Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Shunichiro Nakai; Wataru Matsumiya; Akiko Miki; Shigeru Honda; Makoto Nakamura
Journal:  Jpn J Ophthalmol       Date:  2019-08-02       Impact factor: 2.447

7.  Two-year visual outcome of ranibizumab in typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Masayuki Hata; Akitaka Tsujikawa; Masahiro Miyake; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Hideo Nakanishi; Ayako Takahashi; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-25       Impact factor: 3.117

8.  Single-Nucleotide Polymorphisms Associated With Age-Related Macular Degeneration and Lesion Phenotypes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Maureen G Maguire; Gui-Shuang Ying; Glenn J Jaffe; Cynthia A Toth; Ebenezer Daniel; Juan Grunwald; Daniel F Martin; Stephanie A Hagstrom
Journal:  JAMA Ophthalmol       Date:  2016-06-01       Impact factor: 7.389

9.  Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.

Authors:  Seigo Yoneyama; Yoichi Sakurada; Fumihiko Mabuchi; Mitsuhiro Imasawa; Atsushi Sugiyama; Takeo Kubota; Hiroyuki Iijima
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03-05       Impact factor: 3.117

Review 10.  Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.

Authors:  Michael B Gorin
Journal:  Mol Aspects Med       Date:  2012-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.